Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikel

DOI

    Raphael Schiffmann, Institute of Metabolic Disease, Baylor Research Institute, Dallas, Texas, USA. Electronic address: raphael.schiffmann@baylorhealth.edu., Derralynn A Hughes, Department of Haematology, Royal Free London NHS Foundation Trust, & University College London, UK., Gabor E Linthorst, Department of Endocrinology and Metabolism, Academic Medical Center, Amsterdam, Netherlands., Alberto Ortiz, Unidad de Dialisis, IIS-Fundacion Jimenez Diaz/UAM, IRSIN, Madrid, Spain., Einar Svarstad, Department of Occupational Medicine, Haukeland University Hospital, Bergen, Norway; Institute of Clinical Medicine, University of Bergen, Bergen, Norway., David G Warnock, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Michael L West, Department of Medicine, Dalhousie University, Halifax, Canada., Christoph Wanner, Department of Medicine, Division of Nephrology, University Hospital of Würzburg, Würzburg, Germany. Electronic address: wanner_c@ukw.de., Conference Participants (Erik Ilsø Christensen, conference participant)
OriginalsprogEngelsk
BogserieKidney International. Supplement
Vol/bind91
Tidsskriftsnummer2
Sider (fra-til)284-293
Antal sider10
ISSN0098-6577
DOI
StatusUdgivet - feb. 2017

Se relationer på Aarhus Universitet Citationsformater

ID: 109692273